Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…
Moderna Ebola vaccine, Novo Nordisk, Eli Lilly: Readout Newsletter
National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways…
Novo Nordisk sues Eli Lilly over GLP-1 ads
Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…
Anthropic, Novo Nordisk, Eli Lilly, Medicare: Readout Newsletter
National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
Greenland Mines wins Australian patent for Klotho ALS gene therapy
Greenland Mines (Nasdaq: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 for Klotho gene therapy…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk
WASHINGTON — The Trump administration’s grand bargain with drugmakers on GLP-1s was based on a simple premise: lower…
Novo Nordisk, Pfizer, Roche, Incyte, Treeline: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions
Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA),…
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said…
Genmab director sells 526 shares in Copenhagen | GMAB SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF…